Utrogestan available for HRT

on the 24 August 2007

Utrogestan (progesterone) is a progestogen indicated for the adjunctive use with oestrogen in postmenopausal women with an intact uterus.

The recommended dose is 200mg daily at bedtime, for 12 days, from day 15 to day 26 of each cycle. Withdrawal bleeding may occur in the following week.

Alternatively 100mg can be given at bedtime from day one to day 25 of each cycle, withdrawal bleeding being less with this treatment schedule.

Further information: Ferring 01753 214800

Go to: Utrogestan MIMS drug entry

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter  

More from MIMS

GPs urged to recruit patients for coronavirus trial

GPs urged to recruit patients for coronavirus trial

Chief Medical Officers have written to doctors asking...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Chloroquine and hydroxychloroquine not approved for COVID-19, MHRA cautions

Chloroquine and hydroxychloroquine not approved for COVID-19, MHRA cautions

Chloroquine and hydroxychloroquine should not be used...

Free learning for retired healthcare professionals returning because of coronavirus

Free learning for retired healthcare professionals returning because of coronavirus

MIMS Learning has launched a free learning plan for...